Brief: Granules Update On US FDA Inspection At Gagillapur Facility
Dec 4 (Reuters) - Granules India Ltd GRAN.NS :
* GRANULES - UPDATE ON US FDA INSPECTION AT GAGILLAPUR
FACILITY
* GRANULES INDIA LTD - OAI CLASSIFICATION DOES NOT IMPACT
ONGOING
MANUFACTURING OR DISTRIBUTION
* GRANULES INDIA LTD - OAI STATUS MAY IMPACT REVIEW OF
PENDING
SUBMISSIONS FOR NEW PRODUCTS
Source text: ID:nnAPN2FLDZF
Further company coverage: GRAN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Granules India
See all newsGranules India profit surges as higher sales outweigh cost pressures
Brief: Granules India Q2 Consol Profit 1.82 Billion Rupees
Brief: Granules Says Incorporated Wholly Owned Subsidiary Triton Farmaceutica S.A. De C.V. In Mexico
Brief: Granules Promoter Group Pays 10.93 Billion Rupees For Preferential Issue
Granules India falls after key shareholder trims stake